IN2015DN01737A - - Google Patents
Download PDFInfo
- Publication number
- IN2015DN01737A IN2015DN01737A IN1737DEN2015A IN2015DN01737A IN 2015DN01737 A IN2015DN01737 A IN 2015DN01737A IN 1737DEN2015 A IN1737DEN2015 A IN 1737DEN2015A IN 2015DN01737 A IN2015DN01737 A IN 2015DN01737A
- Authority
- IN
- India
- Prior art keywords
- stem cells
- mesenchymal stem
- culturing
- concentration
- viability
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/02—Atmosphere, e.g. low oxygen conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
- C12N2500/14—Calcium; Ca chelators; Calcitonin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
- C12N2500/16—Magnesium; Mg chelators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/80—Undefined extracts from animals
- C12N2500/84—Undefined extracts from animals from mammals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020120097193A KR101532556B1 (ko) | 2012-09-03 | 2012-09-03 | 간엽줄기세포의 배양 방법 |
| PCT/KR2013/007891 WO2014035215A1 (en) | 2012-09-03 | 2013-09-02 | Method for culturing mesenchymal stem cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN01737A true IN2015DN01737A (ja) | 2015-05-29 |
Family
ID=50183937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1737DEN2015 IN2015DN01737A (ja) | 2012-09-03 | 2013-09-02 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US9580687B2 (ja) |
| EP (1) | EP2893001B1 (ja) |
| JP (1) | JP6478243B2 (ja) |
| KR (1) | KR101532556B1 (ja) |
| CN (1) | CN104781394B (ja) |
| AU (1) | AU2013309642B2 (ja) |
| CA (1) | CA2884000C (ja) |
| DK (1) | DK2893001T3 (ja) |
| ES (1) | ES2755802T3 (ja) |
| IN (1) | IN2015DN01737A (ja) |
| PL (1) | PL2893001T3 (ja) |
| PT (1) | PT2893001T (ja) |
| WO (1) | WO2014035215A1 (ja) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3140417B1 (en) * | 2014-05-09 | 2021-04-21 | Reelabs Private Limited | Foetal polymix of mesenchymal stem cells under hypoxic conditions for the treatment of clinical disorders |
| JP6519727B2 (ja) * | 2014-09-17 | 2019-05-29 | 国立大学法人山口大学 | 間葉系幹細胞の培養方法、および肝機能障害用治療剤の製造方法 |
| US11000694B2 (en) | 2014-10-24 | 2021-05-11 | The Board Of Trustees Of The University Of Illinois | Use of lasers for treating and reversing fibrosis |
| US10287551B2 (en) * | 2014-10-29 | 2019-05-14 | R Bio Co., Ltd. | Medium composition for culturing stem cells |
| TWI740812B (zh) * | 2015-01-05 | 2021-10-01 | 國立陽明大學 | 用於治療肝臟疾病的間葉幹細胞 |
| JP2018512061A (ja) * | 2015-02-20 | 2018-05-10 | ナショナル ヤン−ミン ユニバーシティ | 骨関節炎処置のための間葉幹細胞の使用 |
| US20180200301A1 (en) * | 2015-05-21 | 2018-07-19 | Shanghai Institutes For Biological Sciences Chinese Academy Of Sciences | Low-Oxygen-Treated Mesenchymal Stem Cell and Use Thereof |
| KR102293012B1 (ko) * | 2016-03-31 | 2021-08-27 | 샌바이오, 인크. | 줄기 세포 배양 및 치료를 위한 배지, 방법, 세포 및 분비 인자 |
| US11753623B2 (en) * | 2017-06-05 | 2023-09-12 | The Regents Of The University Of California | Compositions for treating retinal diseases and methods for making and using them |
| CN107384858A (zh) * | 2017-08-17 | 2017-11-24 | 成都康景生物科技有限公司 | 一种缺氧耐受型间充质干细胞的制备方法及其应用 |
| CN109666631A (zh) * | 2017-10-17 | 2019-04-23 | 澳门大学 | 增强干细胞活性的培养方法、应用以及用于治疗中枢神经疾病的制剂、制备方法及治疗方法 |
| CN109706115B (zh) * | 2017-10-26 | 2023-05-30 | 中国医科大学 | 一种小鼠骨髓间充质干细胞细胞系的构建方法 |
| CN108359637B (zh) * | 2018-02-14 | 2021-09-28 | 浙江生创精准医疗科技有限公司 | 一种宫血干细胞快速扩增的方法 |
| CN109517786B (zh) * | 2018-10-18 | 2022-06-17 | 广州元帅生物科技有限公司 | 一种具有修复功能的多能干细胞制剂及其应用 |
| CA3149572A1 (en) * | 2019-08-30 | 2021-03-04 | Ashlee WATTS | Xenogen-free mesenchymal stem cell compositions and methods of use |
| WO2022004938A1 (ko) * | 2020-06-30 | 2022-01-06 | 주식회사 미래셀바이오 | 유사 중간엽 줄기세포의 제조방법 |
| CN112147340B (zh) * | 2020-09-30 | 2024-03-08 | 北京银丰鼎诚生物工程技术有限公司 | 一种神经干细胞免疫调节功能的检测方法 |
| CN112375733B (zh) * | 2020-11-03 | 2022-09-02 | 中国人民解放军陆军军医大学第一附属医院 | 可增进间充质干细胞干细胞性的植物血凝素及其在间充质干细胞扩增培养中的应用 |
| CN113502261B (zh) * | 2021-07-16 | 2023-08-29 | 上海东方星际干细胞科技有限公司 | 一种能高效分化成脂的规模化3d低氧间充质干细胞培养体系 |
| CN116218770B (zh) * | 2022-12-30 | 2023-11-24 | 苏州科为康生物医药科技有限公司 | 一种间充质干细胞的制备方法和应用 |
| CN117660325B (zh) * | 2024-01-31 | 2024-04-19 | 苏州科为康生物医药科技有限公司 | 一种制备脐带血msc的培养基及其方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100494265B1 (ko) | 2001-08-14 | 2005-06-13 | 메디포스트(주) | 관절연골손상 치료용 조성물 |
| WO2003032735A1 (en) * | 2001-10-18 | 2003-04-24 | Lifecell Corporation | Remodeling of tissues and organs |
| ES2287447T3 (es) | 2002-02-19 | 2007-12-16 | Medipost, Co., Ltd. | Metodos de aislamiento y expansion del cultivo de celulas troncales/madre mesenquimatosas a partir de sangre del cordon umbilical, y metodo de diferenciacion de celulas troncales/madre mesenquimatosas derivadas de sangre del cordon umbilical en diversos tejidos mesenquimatosos. |
| WO2004012503A2 (en) * | 2002-07-30 | 2004-02-12 | Tigenix N.V. | Compositions comprising muscle progenitor cells and uses thereof |
| WO2005028678A2 (en) * | 2003-06-06 | 2005-03-31 | Wyeth | Methods and materials for identifying agents which modulate bone remodeling and agents identified thereby |
| JP2006055106A (ja) | 2004-08-23 | 2006-03-02 | National Institute Of Advanced Industrial & Technology | ヒト血清培地を用いるヒト骨髄由来間葉系幹細胞培養法 |
| NZ595786A (en) * | 2005-12-29 | 2013-05-31 | Anthrogenesis Corp | Placental stem cell populations |
| US20070178073A1 (en) * | 2006-02-01 | 2007-08-02 | Samsung Life Public Welfare Foundation | Composition Comprising Separated or Proliferated Cells from Umbilical Cord Blood for Treating Developmental and/or Chronic Lung Disease |
| EP2630959A1 (en) * | 2007-02-12 | 2013-08-28 | Anthrogenesis Corporation | Treatment of inflammatory diseases using placental stem cells |
| US8114668B2 (en) * | 2007-05-14 | 2012-02-14 | Cardiac Pacemakers, Inc. | Composition for cold storage of stem cells |
| KR101022032B1 (ko) * | 2007-07-20 | 2011-03-16 | 동국대학교 산학협력단 | 중간엽 줄기세포를 이용하여 모유두 조직을 제조하는 방법 |
| GB0715648D0 (en) * | 2007-08-10 | 2007-09-19 | Cambridge Silicon Radio Ltd | Channel decoding using similarity matching |
| EP2039758B1 (en) * | 2007-09-21 | 2010-09-01 | Universität Leipzig | Cell culture medium and method for culturing stem cells and progenitor cells |
| US20100330047A1 (en) * | 2009-06-26 | 2010-12-30 | Life & Light Ltd. | Mesenchymal Stem Cells Grown Under Hypoxic Conditions: Compositions, Methods and Uses Therefor |
| KR101243276B1 (ko) * | 2009-10-08 | 2013-03-13 | 서울대학교병원 | 인간 지방 줄기세포의 고활성을 유도하는 방법 및 배지 |
| WO2012018040A1 (ja) * | 2010-08-03 | 2012-02-09 | 北海道公立大学法人札幌医科大学 | 自己血清添加骨髄細胞培養システム、自己血清添加骨髄細胞培養方法および自己血清添加培養骨髄細胞を有効成分とする医薬組成物の製造方法 |
| US20120052577A1 (en) | 2010-08-31 | 2012-03-01 | The Regents Of The University Of California | Culture system for stem cell propagation and neural and oligodendrocyte specification |
-
2012
- 2012-09-03 KR KR1020120097193A patent/KR101532556B1/ko active IP Right Grant
-
2013
- 2013-09-02 WO PCT/KR2013/007891 patent/WO2014035215A1/en active Application Filing
- 2013-09-02 DK DK13833872T patent/DK2893001T3/da active
- 2013-09-02 JP JP2015529690A patent/JP6478243B2/ja active Active
- 2013-09-02 US US14/425,220 patent/US9580687B2/en active Active
- 2013-09-02 PL PL13833872T patent/PL2893001T3/pl unknown
- 2013-09-02 AU AU2013309642A patent/AU2013309642B2/en active Active
- 2013-09-02 EP EP13833872.8A patent/EP2893001B1/en active Active
- 2013-09-02 PT PT138338728T patent/PT2893001T/pt unknown
- 2013-09-02 ES ES13833872T patent/ES2755802T3/es active Active
- 2013-09-02 CA CA2884000A patent/CA2884000C/en active Active
- 2013-09-02 IN IN1737DEN2015 patent/IN2015DN01737A/en unknown
- 2013-09-02 CN CN201380045750.4A patent/CN104781394B/zh active Active
-
2017
- 2017-01-11 US US15/403,457 patent/US10294456B2/en active Active
-
2019
- 2019-03-29 US US16/370,102 patent/US11332715B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR101532556B1 (ko) | 2015-06-30 |
| US10294456B2 (en) | 2019-05-21 |
| EP2893001B1 (en) | 2019-10-30 |
| PL2893001T3 (pl) | 2020-03-31 |
| DK2893001T3 (da) | 2019-12-02 |
| ES2755802T3 (es) | 2020-04-23 |
| KR20140030703A (ko) | 2014-03-12 |
| CN104781394B (zh) | 2017-12-12 |
| AU2013309642A1 (en) | 2015-03-26 |
| US20150284686A1 (en) | 2015-10-08 |
| JP2015532596A (ja) | 2015-11-12 |
| CA2884000C (en) | 2021-08-24 |
| US11332715B2 (en) | 2022-05-17 |
| CN104781394A (zh) | 2015-07-15 |
| US20170191036A1 (en) | 2017-07-06 |
| WO2014035215A1 (en) | 2014-03-06 |
| AU2013309642B2 (en) | 2018-10-25 |
| PT2893001T (pt) | 2019-12-09 |
| CA2884000A1 (en) | 2014-03-06 |
| US9580687B2 (en) | 2017-02-28 |
| EP2893001A1 (en) | 2015-07-15 |
| JP6478243B2 (ja) | 2019-03-06 |
| US20190218517A1 (en) | 2019-07-18 |
| EP2893001A4 (en) | 2016-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015DN01737A (ja) | ||
| GB201105226D0 (en) | Methods | |
| BR112015022770A8 (pt) | meio e sistema de cultivo da célula livre de xenógeno, livre de albumina, forma concentrada, métodos de diferenciação de células-tronco pluripotentes humanas, para a produção de mesenquimoangioblastos e sistema definido de cultivo da célula para diferenciação hematoendotelial das células- tronco pluripotentes humanas | |
| JP2018526992A5 (ja) | ||
| JP2015507921A5 (ja) | ||
| MY160164A (en) | Isolating method for umbilical cord blood-derived pluripotent stem cells expressing znf281 | |
| NZ627091A (en) | Host cells with artificial endosymbionts | |
| WO2012021845A3 (en) | Improved hematopoietic stem and progenitor cell therapy | |
| BR112013002811A2 (pt) | meios básicos simplificados para cultura celular pluripotente de humano | |
| MX364742B (es) | Metodo de cultivo para obtener y mantener una poblacion pura o enriquecida de celulas no diferenciadas neurales y/o celulas progenitoras neurales de mamifero que con propensas a diferenciarse en celulas del linaje oligodendrocitico in vitro. | |
| ZA201206635B (en) | Cell culture medium for the growth and differentiation of cells of the hematopoietic lineage | |
| HK1222198A1 (zh) | 用於提高幹細胞再生能力的培養基組合物及使用它的幹細胞培養方法 | |
| MX366111B (es) | Sistema y sustancias para la crioconservacion de celulas viables. | |
| GB2453074A (en) | Differentiation of primate pluripotent cells to hepatocyte-lineage cells | |
| MX2013005140A (es) | Medios de cultivo de celulas granulados en seco. | |
| WO2011099783A3 (ko) | 지방조직 유래 줄기세포 및 단핵구로부터 세포성장인자의 생산방법 및 그 이용 | |
| PH12016502330A1 (en) | Method for preparing induced pluripotency stem cells from mesenchymal stem cells by using phlorotannin fraction | |
| WO2012074265A3 (ko) | 줄기세포의 안정성 증진용 조성물 | |
| MX2020014123A (es) | Control de niveles de dióxido de carbono y ph en reactores de pequeños volúmenes. | |
| WO2012075462A3 (en) | Methods and compositions for treatment of muscular dystrophy | |
| JP2014522668A5 (ja) | ||
| WO2012124978A3 (ko) | 3차원 세포배양으로 수득한 조정 배지를 유효성분으로 포함하는 허혈성 질환 치료용 약학적 조성물 | |
| WO2011112601A3 (en) | Continuous flow bioreactor for magnetically stabilized three-dimensional tissue culture | |
| WO2014072720A3 (en) | Cell differentiation | |
| WO2012118349A3 (ko) | 제대혈 ｃｄ14 양성 단핵세포로부터 자연살해세포 분화 및 증식 방법 |